GoodRx Holdings, Inc.
GDRX
$2.04
-$0.04-1.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 796.85M | 800.65M | 799.87M | 797.41M | 792.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 796.85M | 800.65M | 799.87M | 797.41M | 792.32M |
| Cost of Revenue | 57.60M | 52.33M | 50.59M | 49.11M | 48.22M |
| Gross Profit | 739.26M | 748.33M | 749.28M | 748.30M | 744.11M |
| SG&A Expenses | 430.52M | 435.58M | 435.52M | 443.31M | 451.62M |
| Depreciation & Amortization | 85.22M | 81.17M | 77.27M | 74.51M | 69.54M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 690.66M | 692.90M | 686.33M | 690.80M | 693.12M |
| Operating Income | 106.20M | 107.76M | 113.54M | 106.61M | 99.20M |
| Income Before Tax | 56.54M | 53.75M | 55.77M | 47.84M | 31.46M |
| Income Tax Expenses | 26.10M | 22.00M | 21.17M | 19.38M | 15.07M |
| Earnings from Continuing Operations | 30.44 | 31.75 | 34.60 | 28.45 | 16.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.44M | 31.75M | 34.60M | 28.45M | 16.39M |
| EBIT | 106.20M | 107.76M | 113.54M | 106.61M | 99.20M |
| EBITDA | 191.41M | 173.16M | 175.05M | 165.36M | 152.98M |
| EPS Basic | 0.08 | 0.09 | 0.09 | 0.08 | 0.04 |
| Normalized Basic EPS | 0.13 | 0.13 | 0.14 | 0.12 | 0.11 |
| EPS Diluted | 0.08 | 0.09 | 0.09 | 0.07 | 0.04 |
| Normalized Diluted EPS | 0.13 | 0.13 | 0.14 | 0.12 | 0.11 |
| Average Basic Shares Outstanding | 1.42B | 1.46B | 1.50B | 1.52B | 1.53B |
| Average Diluted Shares Outstanding | 1.43B | 1.47B | 1.51B | 1.54B | 1.55B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |